N. Cooper

Comprehensive Cancer-Predisposition Gene Testing in an Adult Multiple Primary Tumor Series Shows a Broad Range of Deleterious Variants and Atypical Tumor Phenotypes

William J. Astle, Dorothy A. Thompson, Sri V. V. Deevi, 2018, American journal of human genetics.

KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib

D. Marin, L. Foroni, D. Milojković, 2012, Leukemia.

Interaction between KIR3DS1 and HLA-Bw4 predicts for progression-free survival after autologous stem cell transplantation in patients with multiple myeloma.

K. Rezvani, D. Marin, L. Foroni, 2010, Blood.

through off-target inhibition of kinases important for cell signaling Tyrosine kinase inhibitors impair B-cell immune responses in CML

D. Marin, E. Shpall, D. Milojković, 2013 .

Eltrombopag for the treatment of chronic immune thrombocytopenia

S. Tsiara, N. Cooper, N. Cooper, 2011 .

Eltrombopag – a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations

N. Cooper, L. Cook, N. Cooper, 2010, Drug design, development and therapy.

BACH2 immunodeficiency illustrates an association between super-enhancers and haploinsufficiency

J. Hughes, J. McElwee, P. Wingfield, 2017, Nature Immunology.